AMIE MOTLEY: Open Payments
NPI 1104572452 · SANFORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,146 in 61 payments from 18 companies in 2025. Trend: 2023 $1,786 · 2024 $1,247 · 2025 $1,146
Food & beverage: $1,146
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $415 |
| Lilly USA, LLC | 5 | $97 |
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| Sumitomo Pharma America, Inc. | 3 | $74 |
| Corcept Therapeutics | 2 | $55 |
| PFIZER INC. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Exact Sciences Corporation | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Kowa Pharmaceuticals America, Inc. | 3 | $42 |
Products named: Wegovy, Ozempic, FARXIGA, JARDIANCE, Rybelsus, Korlym, REXULTI, GEMTESA.
Industry payments across NC — which companies pay providers there.
